Nello Mainolfi via YouTube
Atlas-backed Kymera grabs $102M as its protein degradation technology heads into clinic
When Bruce Booth and Nello Mainolfi started planning a protein degradation company, the field was open and sparse, dotted with a couple of hopeful startups …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.